HIGH THROUGHPUT GENOTYPING AND DNA SEQUENCING FOR STUDYING THE GENETIC CONTRIBUTIONS TO HUMAN HEALTH AND DISEASE: WHOLE EXOME SEQUENCING (20X) FOR NEI

用于研究人类健康和疾病的遗传贡献的高通量基因分型和 DNA 测序：NEI 的全外显子组测序 (20X)

• 批准号: 10506204
• 负责人: KIM DOHENY
• 金额: $ 63.95万
• 依托单位: JOHNS HOPKINS UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2021
• 资助国家: 美国
• 起止时间: 2021-09-17 至 2023-09-16
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10506204
• 关键词: Consult; DNA sequencing; Development; Disease; Genes; Genetic Services; Genetic study; Genotype; Health; Hereditary Disease; Human; Institutes; Joints; Mendelian disorder; Peer Review; Process; Research; Research Personnel; Services; Technology; Testing; United States National Institutes of Health; Update; exome sequencing; genetic linkage analysis; human disease

The Center for Inherited Disease Research (CIDR) is a centralized facility established to provide genotyping and statistical genetics services for investigators seeking to identify genes that contribute to human disease. CIDR concentrates primarily on multifactorial hereditary disease although linkage analysis of single gene disorders can also be accommodated. The Center for Inherited Disease Research (CIDR) is a centralized facility established to provide genotyping and statistical genetics services for investigators seeking to identify genes that contribute to human disease. CIDR concentrates primarily on multifactorial hereditary disease although linkage analysis of single gene disorders can also be accommodated. CIDR was established in 1996 as a joint effort by eight institutes at the National Institutes of Health (NIH). It has since expanded to 13 Institutes. An application for CIDR Services is welcome from any investigator, world-wide. Access to CIDR is through a peer-review process.

遗传疾病研究中心（CIDR）是一个集中的机构，旨在为寻求识别导致人类疾病的基因的研究人员提供基因分型和统计遗传学服务。CIDR主要集中在多因素遗传性疾病，虽然单基因疾病的连锁分析也可以容纳。遗传疾病研究中心（CIDR）是一个集中的机构，旨在为寻求识别导致人类疾病的基因的研究人员提供基因分型和统计遗传学服务。CIDR主要集中在多因素遗传性疾病，虽然单基因疾病的连锁分析也可以容纳。CIDR成立于1996年，由美国国立卫生研究院（NIH）的八个研究所共同努力。目前已发展到13个研究所。CIDR服务的应用程序是欢迎来自世界各地的任何调查员。通过同行审查程序获得CIDR。